SISMONDI, Francesca
SISMONDI, Francesca
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Core binding factor acute myeloid leukaemia and c-KIT mutations
2013-01-01 Ludovica Riera; Filippo Marmont; Daniela Toppino; Chiara Frairia; Francesca Sismondi; Ernesta Audisio; Cristiana Di Bello; Stefano D'Ardia; Paola Francia Di Celle; Emanuela Messa; Giorgio Inghirami; Umberto Vitolo; Achille Pich
Core binding factor acute myeloid leukemia and c-kit mutations
2012-01-01 Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
2011-01-01 Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G.
JAK2 V617F activating mutation in chronic myelomonocytic leukemia
2008-01-01 PICH A; RIERA L; SISMONDI F; GODIO L; DAVICO BONINO L; FRANCIA DI CELLE P
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
2009-01-01 Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P.
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia
2012-01-01 Pich A; Riera L; Beggiato E; Nicolino B; Godio L; Campisi P; Sismondi F; Francia di Celle P.
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia.
2010-01-01 L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A.
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA
2010-01-01 Pich A; Riera L; Godio L; Sismondi F; Francia di Celle P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Core binding factor acute myeloid leukaemia and c-KIT mutations | 2013 | Ludovica Riera; Filippo Marmont; Daniela Toppino; Chiara Frairia; Francesca Sismondi; Ernesta Audisio; Cristiana Di Bello; Stefano D'Ardia; Paola Francia Di Celle; Emanuela Messa; Giorgio Inghirami; Umberto Vitolo; Achille Pich | |
| Core binding factor acute myeloid leukemia and c-kit mutations | 2012 | Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U | |
| Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. | 2011 | Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G. | |
| JAK2 V617F activating mutation in chronic myelomonocytic leukemia | 2008 | PICH A; RIERA L; SISMONDI F; GODIO L; DAVICO BONINO L; FRANCIA DI CELLE P | |
| JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia | 2009 | Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P. | |
| JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia | 2012 | Pich A; Riera L; Beggiato E; Nicolino B; Godio L; Campisi P; Sismondi F; Francia di Celle P. | |
| JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. | 2010 | L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A. | |
| JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA | 2010 | Pich A; Riera L; Godio L; Sismondi F; Francia di Celle P |